At the time, BOT's flagship product was a topical acne treatment, whose trial was heading toward completion. The SP was gauged around trial success.
The trial was successful! But... the US portion of the data results showed that the control treatment (placebo) was equally good as the drug.
We never heard why the placebo was a block buster drug, but assume it was a concoction mix up.
As such, the SP tanked.
Bot Chart, page-6995
-
- There are more pages in this discussion • 8,178 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.010(2.70%) |
Mkt cap ! $654.2M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 34.5¢ | $2.959M | 8.301M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 74186 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 422090 | 8 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |